Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-10-01
1995-01-31
Chang, Celia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 514312, 514326, 546157, 546158, 546198, 546209, 540523, A61K 31445, C07D41314
Patent
active
053859162
ABSTRACT:
Certain 1-substituted 4-(1,2-benzisoxazolyl)-piperidine compounds exhibit neuroleptic activity and are useful in the treatment of psychosis and anxiety.
REFERENCES:
patent: 4458076 (1984-07-01), Strupczewski
patent: 4479949 (1984-10-01), Iwao
patent: 4558060 (1985-12-01), Caignard et al.
patent: 4619932 (1986-10-01), Banno et al.
patent: 4777178 (1988-10-01), Nakai
patent: 4801595 (1989-01-01), Archibald et al.
patent: 4831031 (1989-05-01), Lowe et al.
patent: 4921887 (1990-05-01), Matsuo
patent: 5034392 (1991-07-01), Hrib
Janssen et al., J. Pharm. Exp. Ther., 244, No. 2, pp. 685-693, 1988.
Leysen et al., J. Pharm. Exp. Ther., 247, No. 2, pp. 661-670, 1988.
Strupczewski et al., J. Med Chem., 1985, vol. 28, No. 6, pp. 761-769.
Benson Gregg C.
Brokke Mervin E.
Chang Celia
Pfizer Inc.
Richardson Peter C.
LandOfFree
4-(1,2-benzisoxazolyl)piperidine antipsychotic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1102401